Anaphylaxis with Latrodectus Antivenin Resulting in Cardiac Arrest

Journal of Medical Toxicology

Volumn 7, Issue 4, 2011, Pages 317-321

  Murphy, Christine M ^a   Hong, Jeannie J ^b   Beuhler, Michael C ^c  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Carolinas Poison Center   (United States)

Author keywords

Anaphylaxis; Antivenin; Black widow; Latrodectus mactans; Methylene blue

Indexed keywords

ADRENALIN; BICARBONATE; CALCIUM CHLORIDE; DIPHENHYDRAMINE; DOPAMINE; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYDROMORPHONE; IMMUNOGLOBULIN G; KETOROLAC; LORAZEPAM; METHYLENE BLUE; METHYLPREDNISOLONE; NALOXONE; NORADRENALIN; PHENYLEPHRINE; SALBUTAMOL; SPIDER VENOM ANTISERUM; VASOPRESSIN; VECURONIUM; VENOM ANTISERUM;

ADULT; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ARTICLE; ASTHMA; CASE REPORT; DIAPHORESIS; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; ENVENOMATION; HEART ARREST; HEMODYNAMICS; HUMAN; MALE; MEDICAL HISTORY; METERED DOSE INHALER; NAUSEA; NECK; PHYSICAL EXAMINATION; RESUSCITATION; RISK; SHOULDER; SPIDER;

ADULT; ANAPHYLAXIS; ANIMALS; ANTIVENINS; ARACHNIDISM; BLACK WIDOW SPIDER; HEART ARREST; HUMANS; MALE; SPIDER VENOMS;

EID: 82555170267     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-011-0183-1     Document Type: Article

References (38)

1. Litovitz TL, Klein-Schwartz W, White S et al (2000) 1999 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 18(5): 517-574.
2. Litovitz TL, Klein-Schwartz W, White S et al (2001) 2000 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 19(5): 337-395.
3. Litovitz TL, Klein-Schwartz W, Watson WA et al (2002) 2001 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 20(5): 391-452.
4. Watson WA, Litovitz TL, Rodgers GC et al (2003) 2002 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 21(5): 353-421.
5. Watson WA, Litovitz TL, Klein-Schwartz W et al (2004) 2003 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 22(5): 335-404.
6. Watson WA, Litovitz TL, Rodgers GC et al (2005) 2004 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 23(5): 589-666.
7. Lai MW, Klein-Schwartz W, Rodgers GC et al (2006) 2005 Annual Report of the American Association of Poison Control Centers' National Poisoning and Exposure Database. Clin Toxicol 44(6-7): 803-932.
8. Bronstein A, Spyker D, Cantilena L, Green J, Rumack B, Heard S (2007) 2006 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol 45(8): 815-917.
9. Bronstein A, Spyker D, Cantilena L, Green J, Rumack B, Heard S (2008) 2007 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol 46(10): 927-1057.
10. Bronstein A, Spyker D, Cantilena L, Green J, Rumack B, Griffin S (2009) 2008 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol 47(10): 911-1084.
11. Bronstein A, Spyker D, Cantilena L, Green J, Rumack B, Griffin S (2010) 2009 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol 48(10): 979-1178.
12. Clark RF (2001) The safety and efficacy of antivenin Latrodectus mactans. Clin Toxicol 39(2): 125-127.
13. Baba A, Cooper JR (1980) The action of black widow spider venom on cholinergic mechanisms in synaptosomes. J Neurochem 34(6): 1369-1379.
14. Heard K, O'Malley GF, Dart RC (1999) Antivenom therapy in the Americas. Drugs 58(1): 5-15.
15. Rauber A (1983) Black widow spider bites. J Toxicol Clin Toxicol 21(4-5): 473-485.
16. Maretic Z, Stanic N (1954) The health problem of arachnidism. Bull World Health Organ 11: 1007-1022.
17. Bogen E (1926) Arachnidism: a study in spider poisoning. JAMA 86: 1894-1896.
18. Wiener S (1978) Red back spider bite in Australia: an analysis of red-back spider bites. Med J Aust 2: 620-623.
19. Rauber AP (1980) The case of the red widow: a review of latrodectism. Vet Hum Toxicol 22: 39-41.
20. Clark RF, Wethern-Kestner S, Vance MV, Gerkin R (1992) Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann Emerg Med 21: 782-787.
21. Suntorntham S, Roberts JR, Nilsen GJ (1994) Dramatic clinical response to the delayed administration of black widow spider antivenin [letter]. Ann Emerg Med 24(6): 1198-1199.
22. O'Malley GF, Dart RC, Kuffner EF (1999) Successful treatment of latrodectism with antivenin after 90 hours. N Engl J Med 340: 657.
23. Antivenin® [package insert]. Whitehouse Station, NJ: Merck & Co., Inc; 2005 Feb.
24. Hoover NG, Fortenberry JD (2004) Use of antivenin to treat priapism after a black widow spider bite. Pediatrics 114: e128-e129.
25. Wolfe MD, Myers O, Caravati RWF, Seifert SA (2011) Black widow spider envenomation in pregnancy. J Matern Fetal Neonatal Med 24(1): 122-126.
26. Horn WP (1963) Arachnidism in the US. JAMA 185(11): 839-843.
27. McCrone JD, Netzloff ML (1965) An immunological and electrophoretical comparison of the venoms of the North American Lactrodectus spiders. Toxicon 3(2): 107-110.
28. Jurkovich GJ, Luterman A, McCullar K et al (1988) Complications of Crotalidae antivenin therapy. J Trauma 22: 1032-1037.
29. White RR, Weber RA (1991) Posionous snakebite in central Texas: possible indicators for antivenin treatment. Ann Surg 213(5): 466-471.
30. Malasit P, Warrell DA, Chanthavanich P et al (1986) Prediction prevention and mechanism of early (anaphylactic) antivenom reactiosn in victims of snakebites. Br Med J 292: 17-20.
31. Corrigan P, Russeell FE, Wainschell J (1978) Clinical reactions to antivenin. In: Rosenberg P (ed) Toxins: animal, plant and microbial. Pergammon Press, Oxford, pp 457-465.
32. Evora P, Viaro F (2006) The guanylyl cyclase inhibition by MB as vasoplegic circulatory shock therapeutical target. Curr Drug Targets 7: 1195-1204.
33. Kwok E, Howes D (2006) Use of methylene blue in sepsis: a systematic review. J Intensive Care Med 21: 359-363.
34. Maslow A et al (2006) The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg 103: 2-8.
35. Dagenais F, Mathieu P (2003) Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery. Can J Cardiol 19(2): 167-169.
36. Evora P, Simon M (2007) Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue. Ann Allergy Asthma Immunol 99: 306-313.
37. Rodrigues J, Filho A, Rodrigues A, Vicente W, Evora P (2007) Methylene blue for clinical anaphylaxis treatment: a case report. Sao Paulo Med J 125(1): 60-62.
38. Oliveira Neto AM, Duarte NM, Vicente W, Viaro F, Evora P (2003) Methylene blue: an effective treatment for contrast medium-induced anaphylaxis. Med Sci Monit 9(11): CS102-CS106.